U.S., Feb. 27 -- ClinicalTrials.gov registry received information related to the study (NCT06846255) titled 'Comparing DCP and DAP for Pemphigus Vulgaris' on Feb. 24.
Brief Summary: What's the study about?
This study focused on comparing two different treatments for pemphigus vulgaris, a skin condition caused when body's immune system works against itself. The treatments were dexamethasone cyclophosphamide pulse (DCP) therapy and dexamethasone azathioprine pulse (DAP) therapy.
Why was this study done?
The goal of the study was to determine which treatment, DCP or DAP, was more effective in treating pemphigus vulgaris. Both treatments involve high-dose steroids combined with other medications, but they differ in the specific medications ...